This will mark the first worldwide trade show for the device, which is already in use in more than 280 hospitals throughout North America.

As part of Clinical Innovations’ commitment to improving the lives of mothers and their babies throughout the world, the traxi Panniculus Retractor is a device used to safely and effectively hold the panniculus (or excess abdominal skin) during Cesarean delivery particularly on higher risk obese patients to ensure that surgical teams can focus on providing the best possible care.

The traxi device will be one of many innovations in obstetrics and gynecology that will be presented at the FIGO World Congress, an event built around advancing and addressing the many issues that affect women’s health.

FIGO is a worldwide non-profit organization that represents obstetricians and gynecologists throughout 125 countries and territories.
"Recognizing clinical needs and developing safe, reliable, intuitive solutions that can help improve outcomes is part of our core values," said Jeffrey Bradford, Vice President, Global Marketing for Clinical Innovations. "The traxi device is just one example of our extensive product portfolio focused in labor and delivery. We look forward to sharing ideas and new solutions with clinicians at FIGO."

Of the approximately 7,000 expected attendees at the FIGO World Congress, nearly 30 percent will represent the Americas, 30 percent from Asia, 30 percent from Europe and roughly 10 percent from other areas of the world.

Clinical Innovations is the largest healthcare manufacturer exclusively focused on labor and delivery.

Already a market leader in several categories with products such as the Koala Intrauterine Pressure Catheter and Kiwi Vacuum-Assisted Delivery System, Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world.